NYSE Euronext Inc

NYSE Euronext — Q1 2012 Earnings Presentation

18 slides from NYSE Euronext's earnings presentation, Apr 30, 2012

  1. Slide 1: NYSE Euronext First Quarter 2012 Earnings Presentation

    NYSE Euronext First Quarter 2012 Earnings Presentation April 30, 2012 © NYSE Euronext. All Rights Reserved.

  2. Slide 2: Legal Disclaimers

    Legal Disclaimers Disclaimer and Cautionary Note Regarding Forward-Looking Statements This presentation may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, bu

  3. Slide 3: First Quarter 2012 Financial Highlights

    First Quarter 2012 Financial Highlights • Challenging operating environment: lower trading volumes, weaker Euro • Diluted EPS 2 of $0.47 vs. $0.68 Our Results 1 • $601 million in net revenues 3, down 11% • Other operating expenses 4 of $405 million, down 3% on constant dollar / portfolio basis • Ope

  4. Slide 4: Macro Environment Remains Challenging

    Macro Environment Remains Challenging Macro Variables Clouds Silver Linings Derivatives reform Continued uncertainty New opportunities in derivatives products and implementation in delays investment services US and EU Major adjustments to Sell-side cost cutting provides opportunity for bank business

  5. Slide 5: Highlighted Growth Initiatives

    Highlighted Growth Initiatives Clearing Market Infrastructure Build European derivatives clearinghouse Build liquidity centers and connectivity • Phase I on-schedule for summer 2013 • Build out Tokyo liquidity center, • Faster time to market for new products launched Q1 2012 • Operational and capita

  6. Slide 6: Listings Franchise: Momentum in Technology

    Listings Franchise: Momentum in Technology • Since 2008, NYSE Tech penetration has grown from 20% to 59% • Strong pipeline with 118 IPOs on file with NYSE language NYSE Share of Technology IPOs in US 118 Deals Source: Dealogic and NYSE Research, based on number of IPOs 2012 YTD as of 4/20/2012 NYSE

  7. Slide 7: We Continue to Execute Against Our Plans

    We Continue to Execute Against Our Plans Unlocking the Power of the Community Access to GROWTH Operating Leverage Flexibility for Opportunities and Strategic CAPITAL EFFICIENCY Deployment • Announced several • Costs down 3% • ~$125 million in stock new products for constant $ / constant repurchased

  8. Slide 8: GAAP 1Q12 Financial Results

    GAAP 1Q12 Financial Results ($ in millions, except per share data) 1Q12 4Q11 1Q11 Total Revenue¹ $952 $1,054 $1,148 Operating Income $165 $124 $243 Net Income $87 $110 $155 Diluted EPS $0.34 $0.43 $0.59 Pre-tax Adjustments 1Q12 4Q11 1Q11 BlueNext Tax Settlement (net) - ($25) - Severance and Other Ex

  9. Slide 9: Non-GAAP 1Q12 Financial Results

    Non-GAAP 1Q12 Financial Results ($ in millions, except per share data) % ∆ 1Q12 1Q12 4Q11 1Q11 vs. 1Q11 Total Revenue¹ $952 $1,054 $1,148 (17%) Transaction-based Expenses² $351 $426 $469 (25%) Total Revenues, Less Transaction-based Expenses $601 $628 $679 (11%) Other Operating Expenses 3 $405 $416 $

  10. Slide 10: F/X Impact by Segment

    F/X Impact by Segment ($ in millions) Select Financial Highlights $ Variance Attribution 1Q12 1Q11 Total FX Specific Operational % Operational 1 Net Revenue $601 $679 ($78) ($9) ($69) (10%) Operating Expenses2 ($405) ($415) $10 $5 $5 (1%) Operating Income2 $196 $264 ($68) ($4) ($64) (24%) F/X Impact

  11. Slide 11: Derivatives Segment Highlights

    Derivatives Segment Highlights ($ in millions) % ∆ 1Q12 1Q12 4Q11 1Q11 vs. 1Q11 Total Revenue $229 $244 $307 (25%) Net Revenue¹ $176 $186 $236 (25%) % of total 29% 30% 35% Other Operating Expenses² $97 $100 $90 8% Operating Income² $79 $86 $146 (46%) % of total 3 35% 36% 49% Operating Margin ² 45% 4

  12. Slide 12: Derivatives Trading Volumes and Revenue Capture

    Derivatives Trading Volumes and Revenue Capture ($ in millions, except capture and currency data) European Derivatives ADV Contracts in thousands 1Q11 2Q11 3Q11 4Q11 1Q12 8,000 Total Revenue $ 216 $ 187 $ 208 $ 154 $ 147 6,000 5,294 4,633 4,349 Liquidity Payments (45) (39) (50) (32) (33) 771 2,125 3

  13. Slide 13: Cash Trading and Listings Segment Highlights

    Cash Trading and Listings Segment Highlights ($ in millions) % ∆ 1Q12 1Q12 4Q11 1Q11 vs. 1Q11 Total Revenue¹ $602 $683 $726 (17%) Net Revenue² $304 $315 $328 (7%) % of total 51% 50% 48% Other Operating Expenses3 $185 $190 $203 (9%) Operating Income3 $119 $125 $125 (5%) % of total 4 53% 52% 42% Opera

  14. Slide 14: Cash Trading Volumes and Revenue Capture

    Cash Trading Volumes and Revenue Capture ($ in millions, except capture and currency data) European Cash ADV Trades in thousands 1Q11 2Q11 3Q11 4Q11 1Q12 2,000 1,803 1,907 1,540 1,585 1,583 Total Revenue $ 77 $ 72 $ 80 $ 59 $ 59 1,500 Liquidity Payments - - - - - 1,000 Routing and Clearing - - - - -

  15. Slide 15: Info. Services and Tech. Solutions Highlights

    Info. Services and Tech. Solutions Highlights ($ in millions) % ∆ 1Q12 1Q12 4Q11 1Q11 vs. 1Q11 Total Revenue $121 $127 $116 4% % of total 20% 20% 17% Other Operating Expenses1 $93 $96 $88 6% Operating Income1 $28 $31 $28 0% % of total 2 12% 13% 9% Operating Margin 1 23% 24% 24% (1 ppts) EBITDA Margi

  16. Slide 16: Other Operating Expense Reconciliation

    Other Operating Expense Reconciliation ($ in millions) Other Operating Expenses¹ 1Q12 FY 2012 Guidance Current Period ($405) Currency Adjustment ($4) Current Period Rebased2 ($409) ($1,627) - ($1,652) Excluding Impact of: CFD Initiative $2 $12 Clearing Build-Out $2 $15 NYXT Incremental Costs $4 $20

  17. Slide 17: Strong Balance Sheet and Liquidity Position

    Strong Balance Sheet and Liquidity Position ($ in billions) Cash & Investment Securities $0.4 Total Debt $2.1 Key ► 5.375% €1bn notes due June 2015 $1.4 ► 4.8% $750m notes due June 2013 $0.7 Balance Sheet Indicators as of Net Debt $1.7 3/31/2012 Total Debt/EBITDA 2.0X Credit Ratings (S&P/Moody's) A+

  18. Slide 18: NYSE Euronext

    - NYSE Euronext Powering the exchanging world...

NYSE Euronext — Q1 2012 Earnings Presentation on 6ix